Effector CD8+ cytotoxic and CD4+ helper lymphocytes exert anti-tumor effects upon T-cell receptor (TCR) recognition of antigens and proliferative stimulation by IL-2 protein (4). This evidence concerns the gene CD4 and neoplasm.